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SUMMARY
EndoC-bH1 is emerging as a critical human b cell
model to study the genetic and environmental etiol-
ogies of b cell (dys)function and diabetes. Compre-
hensive knowledge of its molecular landscape is
lacking, yet required, for effective use of this model.
Here, we report chromosomal (spectral karyotyping),
genetic (genotyping), epigenomic (ChIP-seq and
ATAC-seq), chromatin interaction (Hi-C and Pol2
ChIA-PET), and transcriptomic (RNA-seq and
miRNA-seq) maps of EndoC-bH1. Analyses of these
maps define known (e.g., PDX1 and ISL1) and
putative (e.g., PCSK1 and mir-375) b cell-specific
transcriptional cis-regulatory networks and identify
allelic effects on cis-regulatory element use. Impor-
tantly, comparison with maps generated in primary
human islets and/or b cells indicates preservation
of chromatin looping but also highlights chromo-
somal aberrations and fetal genomic signatures
in EndoC-bH1. Together, these maps, and a web
application we created for their exploration, provide
important tools for the design of experiments to
probe and manipulate the genetic programs govern-
ing b cell identity and (dys)function in diabetes.
INTRODUCTION
Type 2 diabetes (T2D) is a complex disease characterized
by elevated blood glucose levels. Ultimately, T2D results when
pancreatic islets are unable to produce and secrete enough
insulin to compensate for insulin resistance in peripheral tissues
of the body. Individual genetic variation combined with dietary
and environmental stressors contribute to disease risk and path-
ogenesis (Lawlor et al., 2017b; Mohlke and Boehnke, 2015).
Genome-wide association studies have identified hundreds of
genetic loci associated with T2D and related traits, but extensive
work remains to identify the causal or functional variants, define
their target genes, and determine the roles of these genes in
b cell identity and function. Several studies have employed (epi)
genomic and transcriptomic profiling of human islets (van de
Bunt et al., 2015; Fadista et al., 2014; Varshney et al., 2017), pu-
rified b cells (Ackermann et al., 2016; Blodgett et al., 2015), and
single-cell populations (Lawlor et al., 2017a; Segerstolpe et al.,
2016; Xin et al., 2016) to identify changes in transcriptional regu-
lation and gene expression associated with b cell (dys)function
andT2D.However, themolecular andphysiologic consequences
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of these alterations and their causal link to b cell failure and T2D
pathogenesis remain largely undefined.
With the recent creation of an immortalized human b cell line,
EndoC-bH1 (Ravassard et al., 2011), islet researchers now
possess a tool to experimentally interrogate the molecular
mechanisms governing human b cell identity and (dys)function.
Since the initial report of their creation, studies utilizing EndoC-
bH1 to build insights into human b cell regulation and function
have grown steadily. These studies have demonstrated that the
physiology (e.g., response to glucose and insulin secretion) of
EndoC-bH1 cells resembles that of their primary islet counter-
parts (Andersson et al., 2015; Krizhanovskii et al., 2017; Oleson
et al., 2015; Teraoku and Lenzen, 2017) and that EndoC-bH1
can be used to identify novel genes involved in human insulin
secretion (Ndiaye et al., 2017). To motivate further functional
studies of human b cell molecular biology and guide the
development of cellular models (e.g., for small molecule
screening; Tsonkova et al., 2018), extensive characterization
of the EndoC-bH1 molecular landscape is needed. Here, we
completed multiomic profiling of EndoC-bH1 cells to exten-
sively map (1) chromosomal (spectral karyotyping), (2) 3D
epigenomic and/or chromatin looping (Hi-C [Belton et al.,
2012] and ChIA-PET [Li et al., 2014]), (3) histone modification
(ChIP-seq), (4) chromatin accessibility (ATAC-seq) (Buenrostro
et al., 2013), (5) genetic (dense genotyping and imputation),
and (6) transcriptomic (RNA-seq and miRNA-seq) signatures
of EndoC-bH1. With these high-resolution maps, we sought
to (1) identify gene regulatory programs central to human
b cell identity and function; (2) nominate putative functional
variants, putative molecular mechanisms, and target genes
underlying T2D, glucose, and insulin genetic associations;
and (3) build a publicly available web application for interactive,
intuitive exploration of these data. By comparing these multio-
mic profiles to those generated from human islets in this study
(Hi-C) and parallel studies (Khetan et al., 2018), we identified
shared and unique cis-regulatory elements (cis-REs) and gene
expression features. Taken together, these data, the insights
gleaned from their analysis, and the research support provided
by the web application serve as a high-content resource to
enable and guide future functional assessment and molecular
studies of b cell (dys)function.
RESULTS
Chromosomal and Genetic Heterogeneity in EndoC-bH1
To pursue a precise, comprehensive understanding of the
regulatory networks that govern EndoC-bH1 and/or islet b cell
identity and function, we first investigated the chromosomal
complement and stability of this cell line using spectral karyotyp-
ing (SKY) (Figure 1A). SKY analysis of 14 EndoC-bH1metaphase
spreads revealed that the number of chromosomeswas pseudo-
diploid (n = 46–48) (Figure S1). Nearly all metaphases (n = 13/14)
had a normal XY sex complement, with only one having a
missing Y chromosome, (metaphase 2; Table S1).
The most common autosomal aberrations in EndoC-bH1
included chromosome 20 gains (n = 11/14 metaphases)
and chromosome 10 losses (n = 10/14). Both of these were inde-
pendently detected as copy-number changes by comparative
genomic hybridization (CGH) analysis of the cell line (Univercell
Biosolutions, 2011). As summarized in Figure 1B and Table S1,
we also noted recurrent 10;17 (11/14 metaphases), 7;18 (10/14
metaphases), 3;17 (7/14 metaphases), and 3;21 (7/14 meta-
phases) chromosomal translocations as well as rarer events
including 12;22 (metaphase 1) and 3;5 (metaphase S2.5)
translocations and chromosome 12 losses (2/14 metaphases;
Table S1). Together, these results emphasize that although
EndoC-bH1 is largely diploid, vigilance and caution are war-
ranted when completing and interpreting studies of genes or
cis-REs on chromosomes 3, 7, 10, 17, 18, 20, and 21. We advise
investigators to specifically assess copy-number variation at loci
of interest, particularly in the regions identified herein as unstable
or variable among the population.
Delineation of T2D- and Related-Metabolic-Trait-
Associated GWAS SNP Genotypes in EndoC-bH1
Genome-wide association studies (GWASs) have identified
hundreds of index and linked SNPs representing putative causal
variants at hundreds of loci (Mahajan et al., 2018) associated
with T2D genetic risk and changes in associated quantitative
traits (e.g., fasting glucose, insulin, and proinsulin levels). We
completed dense genotyping and imputation of EndoC-bH1
(STARMethods) to determine the genotypes at2.5 million sites
genome-wide (minor allele frequency, MAF >1%), including
disease-associated SNPs. First, we overlapped EndoC-bH1
genotypes with National Human Genome Research Institute/
European Bioinformatics Institute (NHGRI/EBI) GWAS catalog
(STAR Methods) single lead SNPs associated with glucose
levels (fasting glucose), insulin levels (fasting insulin and proinsu-
lin levels), type 1 diabetes (T1D), or T2D (MacArthur et al., 2017).
EndoC-bH1 exhibited homozygous non-risk genotypes at >50%
of these SNPs (Figure 1C; Table S2). For 20% of analyzed
GWAS loci, EndoC-bH1 possessed a heterozygous genotype,
including rs10830963 at the MTNR1B locus (chr11) and
rs11920090 at the SLC2A2 locus (chr3) (Figure 1D; Table S2).
Overlap with T2D-associated SNPs (n = 6,725 index and linked
[R2 >0.8] SNPs, representing 403 unique signals) reported in
the most recent meta-analysis (Mahajan et al., 2018) revealed
a similar genotype distribution, in which EndoC-bH1was hetero-
zygous for 30% (n = 119/403; Table S2) of T2D signals. These
unique signals represent attractive candidates for (epi)genome
editing to experimentally determine T2D-associated allelic
effects on cis-RE use in human b cells.
The EndoC-bH1 Epigenome and Transcriptome Largely
Resemble Those of Primary Islets but Retain Fetal or
Progenitor Islet Cell Signatures
To identify the genome-wide location of EndoC-bH1 cis-REs
(Figure 2A), we generated chromatin accessibility maps using
ATAC-seq and defined chromatin states (ChromHMM) by
completing and integrating ChIP-seq profiles for multiple histone
modifications. ATAC-seq identified 127,894 open chromatin
sites in EndoC-bH1. Qualitative comparison of EndoC-bH1
open chromatin and chromatin state maps to those in primary
human islets (Khetan et al., 2018; Varshney et al., 2017) revealed
that the genomic architecture for well-known islet-specific loci
such as PCSK1 (Figure 2A), PDX1, and NKX6-1 was remarkably
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similar in both, suggesting EndoC-bH1 cells effectively recapitu-
late b cell cis-regulatory landscapes.
We further compared each ATAC-seq dataset to those from
primary islets, sorted b or a cells, and other primary cell types,
including adipocyte, skeletal muscle, peripheral blood mononu-
clear cells (PBMCs), and CD4+ T cells (STARMethods). We iden-
tified a total of 269,701 open chromatin regions (OCRs) across
all cell types analyzed (STAR Methods). Among all studied
cell types, EndoC-bH1 ATAC-seq profiles most resembled
those of b cells (Figure 2B; Spearman R = 0.67), islets (Fig-
ure 2B; Spearman R = 0.64), and a cells (Figure 2B; Spearman
R = 0.62) (Spearman’s test p values < 2.225 e308).
Next, we compared OCRs and chromatin states to determine
where and to what extent EndoC-bH1 chromatin states recapitu-
lated those of human islets, their constituent cell types, or other
metabolic tissues. EndoC-bH1, islet, and b cell OCRs were
commonly enriched for binding sites of transcription factors
A
B
D
C
Figure 1. Extensive Karyotyping and Geno-
typing of EndoC-bH1
(A) SKY of EndoC-bH1 for a representative
metaphase.
(B) Summary of the frequency of chromosomal
abnormalities across 14metaphases. Black boxes
indicate the presence of an event, while white
boxes indicate an absence.
(C) Bar plots highlighting the risk allele burden of
NHGRI-EBI GWAS Catalog diabetes-associated
GWAS loci in EndoC-bH1. T1D, type 1 diabetes;
T2D, type 2 diabetes. Glucose traits include fast-
ing plasma-glucose- and fasting glucose-related
traits interacting with BMI from the NHGRI-EBI
GWAS catalog (MacArthur et al., 2017). Insulin
traits include proinsulin and fasting insulin traits
interacting with BMI.
(D) Chromosome cartoons illustrating EndoC-bH1
genotypes and the reported locus at glucose trait
GWAS SNPs. Cases in which independent asso-
ciation signals mapped to the same locus are
indicated by the locus name followed by paren-
theses containing numbers of SNPs with each risk
genotype. Chromosomes 10 and 20 are marked
with asterisks to indicate that the previously
observed copy-number alterations (illustrated in
Figure 1B) may obfuscate interpretation of variant
genotypes on these chromosomes.
See also Figure S1 and Table S1.
(TFs) implicated in islet cellular identity
and function (Figure 2C; group III:
FOXA2, FOXO1, RFX, NKX6-1, and
PDX1). EndoC-bH1 OCRs also showed
exclusive enrichment of sequence motifs
that correspond to TFs reported to regu-
late pluripotency and pancreatic progeni-
tor states (Figure 2C; group IV: HNF6,
SOX2, and OCT4), perhaps reflecting the
fetal origin and/or derivation of EndoC-
bH1. At EndoC-bH1 ATAC-seq OCRs,
promoter annotations (from ChromHMM;
STAR Methods) were widely conserved
between EndoC-bH1 and other cell types, including islets as ex-
pected (Figure S2A; centered Pearson correlation >0.95; STAR
Methods). In contrast, enhancers, which often encode cell-spe-
cific transcriptional regulatory elements (Heinz et al., 2015), at
EndoC-bH1 ATAC-seq OCRs were most comparable between
islet and EndoC-bH1 (Figure S2A, black point; centered Pearson
correlation 0.71).
To further assess similarities and differences between islet
and EndoC-bH1 epigenomes, we investigated the proportions
and features of chromatin states that were preserved or dispa-
rate between them. Unsurprisingly, a large proportion of pro-
moters (11,907/19,482; 61%) were preserved (Figure 2D)
and contained motifs for a variety of TFs from the ETS family
(e.g., ELK4, ETS, and ELF1; Table S3) with established roles
in cellular differentiation, proliferation, and apoptosis (Findlay
et al., 2013). Regions annotated as repressed in both islets
and EndoC-bH1 were enriched for CTCF and BORIS binding
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motifs (Table S3), DNA-binding proteins known to bind and
establish transcriptional insulators at chromatin territory bound-
aries. 16,351 out of 51,325 putative enhancers (defined via
ChromHMM) were shared between islets and EndoC-bH1 (Fig-
ure 2D, blue box) and showed strong enrichment for general
(ATF3, AP-1, and JUN) TFs (Figure 2E, blue dots; Table S3)
relative to all enhancer regions. Interestingly, we observed a
substantial number of EndoC-bH1 enhancers that were anno-
tated as quiescent or repressed in islets (n = 19,380) (Figure 2D,
orange box). Relative to all enhancers, these sites were en-
riched for sequence motifs of TFs controlling pluripotency
(OCT2 and NANOG) (Sokolik et al., 2015; Tantin, 2013), pancre-
atic development or lineage specification (HNF6 and ISL1)
(Zhang et al., 2009), and b cell fate determination (PDX1 and
NKX6-1) (Thompson and Bhushan, 2017) (Figure 2E, orange
dots; Table S3). Based on these findings, it is possible that
these regions may represent fetal or developmental cis-REs
that are active in the fetal-derived EndoC-bH1 and inactive in
adult islets composed of mature b cells. Nonetheless, a signif-
icant number of cis-REs (n = 16,351) are conserved between
EndoC-bH1 and human islets.
Next, we measured EndoC-bH1 gene expression using RNA-
seq and compared it to RNA-seq profiles of islets and other cell
types and/or tissues (Figure S2B). As anticipated, the EndoC-
bH1 transcriptome most strongly correlated with transcriptomes
of islets (R = 0.87) and primary b cells (R = 0.86) among all tissues
or cells tested. Of the 27,564 protein coding and/or large
intergenic noncoding RNA (lincRNA) genes considered, 11,554
A B
D E
C
Figure 2. Multiomic Comparative Analysis of EndoC-bH1 and Human Pancreatic Islets
(A) Integrated view of the EndoC-bH1 and human islet (epi)genomic and transcriptomic features surrounding the PCSK1 locus on chromosome 5. Histone
modification ChIP-seq data from EndoC-bH1, human islets, and five Epigenome Roadmap cell types and/or tissues (Roadmap Epigenomics Consortium et al.,
2015) were jointly analyzed to determine ChromHMM-based chromatin states in a uniform manner.
(B) Spearman correlation between EndoC-bH1 ATAC-seq profiles and their corresponding profiles from islets, sorted a or b cells, and other cell types and tissues
(STAR Methods). a, primary islet a cells; b, primary islet b cells; CD4T, CD4+ T immune cell; GM12878, B-lymphoblast cell line; skeletal, skeletal muscle; PBMC,
peripheral blood mononuclear cells. EndoC-bH1 exhibits greatest similarity to islets and their cellular constituents.
(C) Heatmap illustrating Z scores of HOMER enrichment p values for TF motifs in cell-type-specific OCRs.
(D) Comparison of chromatin states between EndoC-bH1 and human islets. Blue box highlights putative enhancer cis-REs in both EndoC-bH1 and human islets;
orange box indicates putative EndoC-bH1 enhancers that are repressed in islets.
(E) TF motifs enriched in genomic regions containing putative enhancer cis-REs in both EndoC-bH1 and islets (blue) or EndoC-bH1 only (orange). Points in gray
denote TFs that are not enriched in either category.
See also Figure S2 and Table S3.
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were expressed in EndoC-bH1 and 12,231 genes were ex-
pressed in islet (with 10,473 genes expressed in both). Similarly,
EndoC-bH1 small non-coding RNA (miRNA) profiles resembled
human islets more than other profiled tissues (adipose, skeletal
muscle; Figure S2C) in principal-component analysis (PCA).
In particular, PC1 loadings were highly correlated with key islet
miRNAs, including miR-375 (Table 1), a critical regulator of
b cell mass and identity (Eliasson, 2017), while PC2 stratified
primary tissue (adipose, skeletal muscle, and islet) from immor-
talized cells (EndoC-bH1). Consistent with the PCA, miRNA
expression levels in EndoC-bH1 and islets were highly correlated
(R = 0.779; Figure S2D), and the vast majority of the most
highly expressed miRNAs in EndoC-bH1 have been reported
previously to be enriched in primary human b cells relative to
whole islets (Table 1) (van de Bunt et al., 2013). Together, the
chromatin accessibility, chromatin state, gene expression, and
small RNA expression analyses reveal substantial conservation
between the transcriptional regulatory and gene expression
landscapes of EndoC-bH1 and primary islets.
Hi-C Profiling of EndoC-bH1 and Human Islets Reveals
b Cell-Specific Chromatin Looping Domains
Next, we sought to determine spatial chromatin organization and
identify chromatin domains both in EndoC-bH1 and islets using
Hi-C. We generated Hi-C maps with 6 billion reads each for
EndoC-bH1 and human islet cells. Themaps have 1.9 billion con-
tacts and 1.5 billion contacts, respectively. Using Juicer (Durand
et al., 2016a) (STAR Methods), we identified 9,100, 2,580, and
9,448 Hi-C loops in EndoC-bH1, human islet, and GM12878
(a human lymphoblastoid cell line) (Rao et al., 2014), respectively.
The reduced number of Hi-C loops identified in primary islet may
be attributed to lower unique read depth (3.7 billion unique
reads in islet cells versus 4.7 billion unique reads in EndoC-
bH1) (Table S1). Together, this represents 19,428 independent
DNA loops. Aggregate peak analyses (APAs) (Rao et al., 2014)
(Figure 3A, top plots) revealed that chromatin looping sites (an-
chors) were comparable in EndoC-bH1, islets, and GM12878
for the majority of (>90%) the total chromatin loops (n = 19,428/
21,128). Consistent with previous studies (Rao et al., 2014; Vietri
Rudan et al., 2015), CTCF and CTCFL DNA-binding motifs were
overwhelmingly enriched (p < 1e-229 and p < 1e-114, respec-
tively) among all Hi-C anchor sequences (Table S4), verifying
that general 3Dchromatin structures and loops arepreservedbe-
tween different mammalian tissues and cell types. Importantly,
however, we detected 1,078 and 117 chromatin loops that
were exclusively present in EndoC-bH1 and islet, respectively,
compared to GM12878 (Figure 3A, bottom plots).
To further study cell-specific loops, we subdivided EndoC-
bH1 and GM12878 differential Hi-C loops into three classes
based on the cell type specificity of the ATAC-seq OCRs they
bring into physical proximity (Figure 3B): (A) loops between two
non-specific OCRs, (B) loops between two cell-specific OCRs,
or (C) loops between one cell-specific OCR and one non-specific
OCR. Class B/C loops were classified as cell-specific and further
studied. Comparison of EndoC-bH1-specific (n = 315) and
GM12878-specific (n = 308) loops revealed a strong bias for
cell-specific TF binding at anchor sites (Figure 3C). In EndoC-
bH1-specific anchors, we observed enrichment for TFs involved
in b cell differentiation and function (NKX6-1, FOXA2, and
FOXA1) (Thompson and Bhushan, 2017) as well as OCT4, a
key regulator for early embryo development (Le Bin et al.,
2014; Wu and Scho¨ler, 2014), while GM12878-specific anchors
were enriched for TFs necessary for B cell proliferation and acti-
vation (MEF2C and NFAT) (Herglotz et al., 2016; Peng et al.,
2001). Furthermore, genes adjacent to EndoC-bH1-specific
anchors (STAR Methods) were most enriched (hypergeometric
false discovery rate [FDR]-adjusted p value < 0.05) for islet-asso-
ciated gene ontology (GO) terms, including insulin secretion,
glucose homeostasis, and neuronal or endocrine development
(Figure S3A; complete results are shown in Table S4). For several
genes affiliated with these GO terms, such as SLC30A8, which
encodes a zinc efflux transporter involved in zinc ion seques-
tering and insulin secretion (Mitchell et al., 2016), we observed
striking similarities in Hi-C contact frequencies between islet
and EndoC-bH1 cells (Figure 3D). In contrast, we observed far
fewer chromatin loops and large spans of polycomb-repressed
and/or quiescent chromatin for this locus in GM12878 cells
(Figure 3E).
Table 1. Top 25 Expressed miRNAs in EndoC-bH1 Cells
miRNA
EndoC-bH1
Rank
EndoC-bH1
RPMMM
b Cell
Enrichment /
Depletion
hsa-miR-375 1 162076.925 2.84
hsa-miR-127-3p 2 90512.35 –
hsa-miR-27b-3p 3 85043.195 3.09
hsa-miR-192-5p 4 70126.5525 2.01
hsa-miR-192-5p_+_1 5 37621.0275 –
hsa-miR-182-5p 6 36662.2475 2.15
hsa-miR-22-3p 7 29623.8 2.87
hsa-miR-191-5p 8 25424.1575 3.02
hsa-miR-26a-2-5p 9 15578.9175 2.94
hsa-miR-26a-1-5p 10 15496.7075 2.94
hsa-miR-141-3p 11 13656.6825 2.84
hsa-miR-92a-1-3p 12 13615.6425 2.30
hsa-miR-30d-5p 13 11108.9275 0.75
hsa-miR-654-3p 14 11107.385 –
hsa-miR-148a-3p 15 10651.885 2.22
hsa-miR-200b-3p 16 10266.2575 1.48
hsa-miR-92a-2-3p 17 10161.165 2.30
hsa-miR-381 18 9342.8875 1.08
hsa-miR-25-3p 19 9230.2225 1.98
hsa-miR-181a-1-5p 20 8702.47 1.81
hsa-miR-181a-2-5p 21 8702.3125 1.81
hsa-miR-21-5p 22 8439.755 0.21
hsa-miR-183-5p 23 8338.08 1.58
hsa-miR-92b-3p 24 7531.295 4.63
hsa-miR-125a-5p 25 6743.8375 1.24
Table consisting of the top 25 expressed miRNAs in EndoC-bH1 cells.
Each miRNA rank was determined by its corresponding expression level
(reads per million mapped miRNA [RPMMM]). b cell enrichment / deple-
tion was determined by dividing the counts of eachmiRNA in b cells (from
van de Bunt et al., 2013) by the counts in islets.
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Approximately 50% (4,543/9,100) of EndoC-bH1 loop anchors
overlapped EndoC-bH1ATAC-seqOCRs, 44% (n = 1,987/4,543)
of which occurred between promoter and enhancer elements
(Figure S3B). Of these 4,543 loops, 587 were specifically present
in EndoC-bH1 yet absent in GM12878 cells (EndoC-bH1 spe-
cific); the remaining 3,956 were captured in both EndoC-bH1
andGM12878 (non-specific). We observed a substantially higher
proportion (64%; 376/587) of EndoC-bH1-specific loops that
overlapped EndoC-bH1 stretch enhancers (Parker et al., 2013)
(Fisher’s exact test p value < 4.23 e-42) compared to that of
nonspecific loops (34%; 1,358/3,956). To examine the functional
specificity of these loops, we overlapped chromatin state
(ChromHMM) information from EndoC-bH1 and 27 other tissue
or cell types for all EndoC-bH1 Hi-C loops. For each cell type,
we determined the percentage of Hi-C anchors that contained
the same chromatin state as EndoC-bH1 (STARMethods). Islets
had the highest percentage of chromatin states identical to
EndoC-bH1 at Hi-C anchor sites among all tested tissues or
A
B
C
D
E
Figure 3. Generating a Genome-wide Map of Looping in EndoC-bH1 and Human Pancreatic Islets (Hi-C)
(A) Aggregate peak analysis (APA) plots showing the total signal across all loops (top three panels) and EndoC-bH1-specific loops (bottom three panels) in EndoC-
bH1 (left), human islet (center), and GM12878 (right) cells. Of note, islets exhibit similar contact point enrichments at EndoC-bH1-specific peaks compared to
GM12878.
(B) Cartoon illustrating the different classes of Hi-C loops between example common (gray peaks) or cell-specific (black peaks) ATAC-seq OCRs for two different
theoretical cell types.
(C) TF motifs enriched in GM12878 (blue) or EndoC-bH1 (red) Hi-C looping anchors that overlap cell-specific ATAC-seq peaks loop classes B and C in panel B
above).
(D) Hi-C contact maps highlighting a specific loop at the SLC30A8 locus (denoted by dotted black circle) observed in both EndoC-bH1 (left) and primary human
islets (center) but absent in GM12878 (right).
(E) Multiomics view of Hi-C, ChIA-PET (Pol2), chromatin states, ATAC-seq, RNA-seq, and gene tracks at the SLC30A8 neighborhood containing the Hi-C contact
point highlighted in (D). Tracks corresponding to EndoC-bH1, human islet, and GM12878 are colored red, black, and blue, respectively. Dark blue boxes below
each gene name represent the reference transcript annotations derived from Gencode v19. The red arrow at the bottom of the image indicates the putative
EndoC-bH1- and islet-specific promoter for SLC30A8. The black arrow indicates the putative embryonic stem cell and K562 cell-specific promoter for SLC30A8
(Roadmap Epigenomics Consortium et al., 2015).
See also Figure S3 and Table S4.
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cell types, especially promoter-enhancer loops (Figure S3C; or-
ange line plot). These findings enumerate regions of cell-specific
chromatin looping associated with islet development and func-
tion and indicate that EndoC-bH1 forms cell-type-specific chro-
matin domains or territories highly similar to primary human islets.
EndoC-bH1 Pol2 ChIA-PET Identifies b Cell cis-
Regulatory Hubs
To map functional cis-regulatory networks, we completed RNA
polymerase (Pol2) ChIA-PET (Li et al., 2017b) in EndoC-bH1,
identifying 25,336 putative Pol2-mediated chromatin interac-
tions. We further filtered these interactions, retaining only those
for which both interacting sites (ChIA-PET anchors) overlapped
EndoC-bH1 ATAC-seq OCRs, resulting in 16,756 putative cis-
regulatory interactions (STAR Methods). As shown in Figure 4A,
the overwhelming majority of Pol2-mediated chromatin interac-
tions linked active enhancer and active promoter chromatin
states to themselves and each other. Importantly, ChIA-PET de-
tected EndoC-bH1-specific interactions (Figure 4B; compare
EndoC-bH1, GM12878, and K562 ChIA-PET tracks) coinciding
with those previously reported in targeted 4C-seq analyses of
human islets (Pasquali et al., 2014), including the ISL1 (Figure 4B;
n = 8 sites denoted by asterisks) and PDX1 (Figure S4A; n = 9
sites) loci.
In addition to replicating interactions previously studied by
4C-seq in human islets, Pol2 ChIA-PET identified hundreds of
additional promoter-promoter and promoter-enhancer interac-
tions genome-wide (Figure 4C; STAR Methods). These include
extensive Pol2 interactions in loci containing genes crucial for
b cell identity and development such as PDX1, ISL1, NKX6-1,
MAFB, and miR375 (Figure 4C, red text). As shown in Figures
4C and S4A, multiple interactions were detected between the
PDX1 promoter and classically described essential PDX1 tran-
scriptional enhancer sequences (n = 7/14 enhancer interactions),
which contain binding sites for islet TFs such as FOXA2 (Gao
et al., 2008; Gerrish et al., 2004). During embryonic development,
C57BL/6 mouse pancreata displayed a transition in expression
of MafB to MafA (Nishimura et al., 2006), suggesting that these
two factors are tightly involved in b cell differentiation and func-
tion. The high degree of connectivity in MAFB (versus that of
MAFA) may therefore reflect the fetal or naive state of EndoC-
bH1 cells.miR375, a small non-coding RNA, possessed multiple
connections to active promoter and enhancer elements (Fig-
ure 4C; red text), consistent with its role as a post-transcriptional
regulator of genes involved in b cell development or differentia-
tion and insulin secretion or exocytosis (Eliasson, 2017).
Interestingly, INSM1, a gene necessary for pancreatic endo-
crine cell differentiation (Osipovich et al., 2014), harbored the
most connections in EndoC-bH1 (n = 97 total interactions,
n = 7 between active promoters and enhancers; Figure S4B).
Other genes linked by ChIA-PET interactions are involved in
insulin processing and secretion, including PCSK1, one of the
prohormone convertases that catalyzes (pro)insulin processing;
RIMBP2, whose protein mediates formation of a complex for
polarized accumulation and exocytosis of insulin granules (Fan
et al., 2017); RGS7, a critical regulator of muscarinic-stimulated
insulin secretion (Wang et al., 2017); andCDC42, which is essen-
tial for second-phase insulin secretion (Wang et al., 2007). Addi-
tionally, genes implicated in the protection and management of
stress were highly connected in EndoC-bH1 ChIA-PET interac-
tions. Notable candidates were ZFAND2B, whose induction
helps protect against human b amyloid peptide toxicity or accu-
mulation in a C. elegans transgenic Alzheimer’s disease model
(Hassan et al., 2009); SUSD4, a complement inhibitor and
tumor suppressor that modulates endoplasmic reticulum stress;
and CD59, which is required for mediating exocytosis events
facilitating insulin secretion (Blom, 2017; Krus et al., 2014).
Finally, TSHZ1, a PDX1 target gene whose expression levels
were notably lower in human islet donors with T2D (Raum
et al., 2015), harbored five links to active enhancer elements in
EndoC-bH1, suggesting that perturbation of the cis-regulatory
networks identified herein may contribute to T2D pathogenesis.
Finally, we sought to study to what extent the putative cis-reg-
ulatory networks detected in EndoC-bH1 may be preserved in
islets and other cell types. Due to limited availability of ChIA-
PET data in human islets and other relevant tissues, we decided
to use the chromatin interaction sites determined by EndoC-bH1
ChIA-PET and compare the functional annotations (ChromHMM
state annotations) at these loci across 27 different tissue or cell
types. Overall, aggregate counts of these chromatin state inter-
actions for each cell type weremost similar between EndoC-bH1
and islet (Figure 4D, green bar plots; STAR Methods). ChIA-PET
interactions between regions annotated as active promoters in
EndoC-bH1were similarly annotated as active promoters across
the 27 other cell or tissue types (Figure 4D, Act. promoter3 Act.
promoter, red line plot; STAR Methods). In contrast, the majority
of active enhancers interacting in EndoC-bH1 were marked
as active enhancers only in human islets (Figure 4D, Act.
Enhancer x Act. Enhancer, yellow line plot). Multidimensional
scaling of all cell or tissue chromatin state annotations at
EndoC-bH1 ChIA-PET interacting sites reaffirmed high similarity
between EndoC-bH1 and islets (Figure S4C), consistent with
strong conservation of active enhancer state annotations, as
previously observed (Figure 4D, line plots). These results sug-
gest that these interactions may represent b cell cis-regulatory
hubs. Indeed, anchors for 41% of ChIA-PET interactions
(6,904/16,756) overlapped islet stretch enhancers, suggesting
that these interactions may encompass key islet functional chro-
matin domains.
Integration of EndoC-bH1 Genotype and 3D Genomic
Interaction Maps Identifies Allelic Imbalance at b Cell-
Specific cis-REs
We and others have demonstrated that genetic variants,
including those associated with T2D and other quantitative mea-
sures of islet (dys)function, can alter cis-RE use (chromatin
accessibility quantitative trait loci [caQTL]) (Khetan et al., 2018)
and target gene expression (expression quantitative trait loci
[eQTL]; van de Bunt et al., 2015; Fadista et al., 2014). Recently,
approaches have been used to assess allelic effects on these
molecular features at heterozygous sites within a single sample.
We applied these allelic imbalance (AI) analyses in EndoC-bH1 to
identify genetic variants that alter b cell cis-REs and target gene
expression. To identify instances of AI in EndoC-bH1, we exam-
ined the allelic bias of 2 million heterozygous SNPs (STAR
Methods) within OCRs (ATAC-seq peaks), active enhancer
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elements (H3K27ac peaks), or expressed genes (RNA-seq; Fig-
ure 5A). Less than 10% of all SNPs occurring in OCRs and
enhancer elements showed significant AI (Figure 5A; part I;
FDR <10%). Approximately 25% of SNPs exhibited gene
expression AI (Figure 5A). When considering variants with
adequate coverage in both EndoC-bH1 ATAC-seq OCRs and
H3K27ac-marked enhancer regions (n = 1,734 SNPs), we noted
a positive correlation (R = 0.2) in the corresponding AI ratios (Fig-
ure S5A), suggesting the potential for coordinate regulation
of chromatin accessibility and histone modification at these
A B
DC
Figure 4. RNA Polymerase 2 ChIA-PET Identifies Chromatin Interactions in EndoC-bH1
(A) Heatmap showing the chromatin states of EndoC-bH1 ChIA-PET interaction nodes.
(B) Example of a Pol2 ChIA-PET interaction between active enhancer (blue box) and active promoter (green box) cis-REs in the ISL1 locus on chromosome 5.
Asterisks under EndoC-bH1ChIA-PET interactions (red) indicate interacting sites in the ISL1 locus detected in human islet 4C-seq analyses (Pasquali et al., 2014).
(C) ChIA-PET network connectivity of gene promoters in EndoC-bH1 containing at least three interactions with other regulatory elements. For each gene, the
number of connections between other regulatory elements (e.g., active enhancer and weak enhancer) and the proportion of total links in which the chromatin
states are EndoC-bH1-specific (blue) or identical in both human islet and EndoC-bH1 (green) are shown in bar plots on the right. The remaining proportions that
are neither EndoC-bH1 specific nor common to islet and EndoC-bH1 are not shown. Red font denotes loci containing genes crucial for b cell identity and
development.
(D) Top: Bar plot illustrating the proportions of chromatin states at the Pol2 ChIA-PET interacting sites (nodes) shared between EndoC-bH1, islets, and additional
Epigenomics Roadmap tissues and cell lines. Bottom: Heatmap demonstrating the chromatin states of EndoC-bH1 Pol2 ChIA-PET interacting sites (nodes) in
islets (left) or stomach smooth muscle (right).
See also Figure S4.
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cis-regulatory sites. In total, 119 out of 403 T2D-associated
signals (30%) overlapped EndoC-bH1 cis-REs (Table S2); 34
out of 119 of these unique signals (29%) were heterozygous
in EndoC-bH1 and potentially amenable to allelic analyses.
GREGOR (Schmidt et al., 2015) enrichment analysis of these
same 403 signals identified significant overlap (p value < 1 e-7)
in EndoC-bH1 ATAC-seq (n = 67 SNPs) OCRs.Moreover, 24,102
out of 126,013 of T2D-associated 99% genetic credible set
SNPs (19%) (Mahajan et al., 2018), representing 327 out of 380
distinct association signals (86%), overlapped an EndoC-bH1
ATAC-seq OCR and/or H3K27ac peak. These overlaps suggest
that EndoC-bH1 may be a useful tool to dissect the function of
cis-REs implicated in T2D genetic risk.
Next, we leveraged information from EndoC-bH1 ChIA-PET
interactions to determine potential allelic effects on cis-regulatory
networks and target gene expression. To achieve this, we (1) iden-
tified SNPs overlapping enhancers with AI (H3K27ac and/or
ATAC-seq), (2) determined if the SNP-containing enhancer linked
(viaChIA-PET) to the transcription start site (TSS) of a gene, and (3)
assessed if SNPs in the promoter or transcribed region of the pre-
dicted target gene exhibited AI in H3K27ac and/or ATAC-seq or
RNA-seq, respectively (Figure 5B). For example, rs2294805 ex-
hibited AI in an EndoC-bH1 enhancer downstream of SAMD5
and was linked to this gene’s TSS by a ChIA-PET interaction
(Figure 5C). Notably, 5 out of 11 transcribed SAMD5 SNPs ex-
hibited significant AI in RNA-seq gene expression data. In all
cases, one parental allele (denoted in blue) was consistently over-
represented in both H3K27ac ChIP-seq and RNA-seq data.
Although the exact role of SAMD5 in human islets has not been
described, expression of this gene is high in adult a cells but ab-
sent in adult b cells (Lawlor et al., 2017a; Segerstolpe et al.,
2016; Wang et al., 2016). SAMD5 has been recently identified as
B
C
A
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Figure 5. Allelic Effects on EndoC-bH1 Transcriptional Regulatory Features
(A) EndoC-bH1 genotype information was integrated with ATAC-seq, H3K27ac, and RNA-seq data to identify sequence variants altering cis-RE accessibility and/
or activity (ATAC-seq and H3K27ac) or mRNA levels (RNA-seq) in EndoC-bH1. Pie charts summarize the proportions of variants exhibit significant AIs (blue;
FDR < 10%) in each of the corresponding sequencing profiles.
(B) Cartoon representation of approach to identify systematic allelic effects on EndoC-bH1 cis-regulatory networks.
(C) Multiomic view highlighting allelic effects on the SAMD5 locus cis-regulatory network in EndoC-bH1. A variant site exhibiting significant AI in H3K27 acet-
ylation (denoted by blue arrow) is linked (red ChIA-PET interaction) to the transcription start site (TSS) of SAMD5.Within the SAMD5 locus, five transcribed SNPs
exhibited significant allelic bias in gene expression (RNA-seq) in a direction consistent with the H3K27ac allelic bias.
(D) Left: Bar plots summarizing the proportions of variants with ATAC-seq/H3K27ac imbalance (blue bars; FDR < 10%) that overlap ChIA-PET interacting loci.
Right: Pie charts specifying the chromatin state (ChromHMM) annotations of the overlapping variants.
See also Figure S5 and Table S5.
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a marker of peribiliary gland (PBG) cells (Yagai et al., 2017), and
PBG stem cells have been documented to differentiate into
glucose-responsive pancreatic islets (Cardinale et al., 2011).
These data identify SAMD5 as one of the most highly connected
loci in EndoC-bH1 (Figures 4C andS4B; n = 35ChIA-PET connec-
tions between the gene and active enhancers; n = 5 interactions to
otheractivepromoters) andhighlight apotentialcis-regulatoryhub
for fetal b and islet cell development. Further manipulation of the
cis-regulatory network in this locus may provide greater insight
into its putative roles in islet cell differentiation and function.
Overall, 2,500 out of 5,515 (45%) and 8,794 out of 43,492
(20%) of heterozygous SNPs passing coverage thresholds
(STAR Methods) in ATAC-seq and H3K27ac cis-REs, respec-
tively, overlapped a ChIA-PET anchor (Figure 5D, bar plots).
For both datasets, <5% of SNPs demonstrated significant AI.
AI SNPs were present in active promoter and enhancer regions
of the genome (Figure 5D, pie charts marked with blue arrows).
Enhancers exhibited enriched AI compared to promoters. For
example, in the ATAC-seq data, 49.5% of AI SNPs occurred
in enhancers compared to 30.9% of non-AI SNPs (Fisher’s
exact test p value = 0.0002824 for comparison of enhancer
versus promoter counts). Similarly, 54.6% of H3K27ac AI SNPs
occurred in enhancers compared to 43% of non-AI SNPs
(Fisher’s exact test p value = 3.343e-05 for comparison of
enhancer versus promoter counts) (Figure 5D).
Enhancers govern cell-type-specific gene expression patterns
(Heinz et al., 2015).We identified 50 and 185 enhancer SNPswith
significant ATAC-seq and H3K27ac AI, respectively (Figure 5D,
yellow portion of pie charts marked with blue arrows). We used
ChIA-PET interactions to link enhancers showing AI to promoters
of the genes they might regulate (Table S5). This identified
enhancer-promoter links for 21 out of 50 (42%) ATAC-seq and
91 out of 185 (49%) H3K27ac AI enhancer SNPs, respectively.
To assess if observed allelic effects on EndoC-bH1 cis-regula-
tory networks extended to primary islets, we examined the
eQTL direction of effect of these SNPs on steady-state expres-
sion of their predicted target genes in human islets (Varshney
et al., 2017). Islet eQTL Z scores (STAR Methods) were most
correlated to the H3K27ac allelic ratio at SNPs where the human
islet eQTL target gene (i.e., the gene whose expression in human
islets is influenced by a genetic variant) matched that of the
EndoC-bH1 ChIA-PET target gene (i.e., the gene linked to the
enhancer by EndoC-bH1 ChIA-PET as depicted in Figure 5B)
(n = 42/91) (Figure S5B, red points; R = 0.32), as opposed to
those genes in the locus that were not linked to the enhancer
by ChIA-PET (Figure S5B, gray points; R = 0.17).
Importantly, these analyses suggest that integrated EndoC-
bH1 omics analyses provide molecular insights into diabetes
genetics (e.g., GWAS). For example, T2D-associated index
and 99% credible set SNP rs57235767, for which the ‘‘C’’ risk
allele exhibited reduced EndoC-bH1 H3K27ac counts, exhibited
consistent downregulation of the ChIA-PET-predicted target
gene C11orf54 (Figure S5B, asterisk) expression in islet cohorts
(Fadista et al., 2014; Varshney et al., 2017). Similarly, the T2D
risk allele of rs3807136, a 99% credible set SNP in linkage
disequilibrium (r2 > 0.8) with the index and 99% credible set
SNP rs2268382, displayed a higher proportion of H3K27ac
counts in EndoC-bH1 and increased expression of the predicted
target gene, CEP41. These human islet SNP-gene interactions
(that are also recapitulated in EndoC-bH1 cells) represent high-
priority targets for (epi)genomic modification and should assist
efforts to decrypt the genes contributing to T2D pathogenesis.
DISCUSSION
Here, we report extensive multiomic mapping and integrated
analysis of cytogenetic (karyotyping), large-scale chromatin
structural conformation (Hi-C), cis-regulatory networks (ChIA-
PET), histone mark (ChIP-seq), chromatin accessibility (ATAC-
seq), genetic (genotyping), and gene expression (RNA-seq)
information in EndoC-bH1 human b cells. For convenient and
interactive browsing of this data, we have created an R shiny
web application (Chang et al., 2018) available at https://
shinyapps.jax.org/endoc-islet-multi-omics/. These data and
the browser application should serve as a resource for future
studies to explore the complex b cell regulatory programs un-
covered in this study and guide targeted studies of regulatory
networks, genes, and pathways of interest.
SKY revealed chromosomal heterogeneity among individual
cells in the EndoC-bH1 population. These included copy number
variation, such as chromosome 20 gain and chromosome 10
loss, that has been identified independently by array CGH ana-
lyses, as well as previously unappreciated structural alterations,
including chromosome 10:17 and 3:21 translocations, that
are frequent within the population. Consistent with SKY,
we observed enhanced contact frequency between chromo-
somes 3 and 21 in EndoC-bH1 Hi-C maps (Juicebox [Durand
et al., 2016b]; http://aidenlab.org/juicebox/?juiceboxURL=http://
bit.ly/2NxWcDp), suggesting that these two technologies may
complement one another to identify cell line abnormalities. As evi-
denced by other less prevalent chromosomal aberrations among
the population, it is possible that this cell line may continue to
evolve with continued passaging. Thus, caution should be taken,
and these aberrations shouldbeconsidered, in future (epi)genome
editing or EndoC-bH1 molecular and functional experiments
involving genes or regulatory elements on these chromosomes.
Overall, comparative analyses of omics profiles indicate sub-
stantial similarity among EndoC-bH1, islet, and primary b cell
transcriptomes (Figure 2B; Pearson R > 0.86). EndoC-bH1
open chromatin profiles were modestly correlated with islet
(R = 0.64) and primary b (R = 0.67) cells, highlighting potential drift
between the cell line and primary islet cells at the level
of chromatin accessibility. This includes 19,000 putative
EndoC-bH1 enhancers annotated as quiescent or polycomb
repressed in human islets. Interestingly, these sites contain po-
tential binding sites for TFs with important roles in b cell develop-
ment andpancreatic precursor fates and functions (e.g., NKX6-1,
PDX1, ISL1, and HNF6) (Thompson and Bhushan, 2017) and plu-
ripotency (e.g., NANOG and OCT2) (Sokolik et al., 2015; Tantin,
2013). Thus, thesediscordant featuresmay reflect the fetal nature
of EndoC-bH1 cells, their transformed state, or both.
Using Hi-C tomap higher-order chromatin structure in EndoC-
bH1 and a corresponding map from a human islet donor, we
defined islet and b cell chromatin domains and territories.
Consistent with previous findings (Rao et al., 2014), the overall
spatial chromatin organization was similar across EndoC-bH1,
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islet, and GM12878 cells (Figure 3A; top panel), and all Hi-C
anchors were enriched for TFs with general roles in chromatin
organization (e.g., CTCF and BORIS; Table S4). Importantly,
however, Hi-C analyses also identified 1,078 islet and b cell-
specific chromatin domains, several of which were evident in
both EndoC-bH1 and primary human islets (Figure 3). These
cell-specific chromatin territories were enriched for b cell-spe-
cific TFs (Figure 3C) and brought into close physical proximity
genes linked to islet-associated biological process GO terms
(Figure S3A) compared to those of GM12878.
Here, we also report a Pol2 ChIA-PET map of chromatin inter-
actions in EndoC-bH1, which further refined chromatin territories
to reveal functional EndoC-bH1 cis-regulatory networks. In addi-
tion to validating chromatin interactions previously reported in
4C-seq analyses at select loci in human islets, Pol2 ChIA-PET
identified hundreds of interactions genome-wide between active
promoter and enhancer regions potentially involved in the
regulation and transcription of dozens of b cell-specific loci (Fig-
ures 4A–4C). Comparison of Pol2 ChIA-PET interaction locations
in EndoC-bH1, GM12878, and K562 revealed that the over-
whelming majority of interactions at these loci were unique to
EndoC-bH1. Due to high cell input requirements (100 million
cells) for current ChIA-PET library construction protocols (Li
et al., 2017b), wewere unable to validate these findings in human
islets. However, consistent with our previous observations be-
tween islet and EndoC-bH1 Hi-C maps (Figure S3C), we noted
that chromatin states of ChIA-PET interaction nodes in EndoC-
bH1 were most conserved in islet (Figure 4D, Figure S4C)
compared to those of 27 other cell or tissue types. Thus, the
cis-regulatory programs we define for EndoC-bH1 should pro-
vide valuable insights into important transcriptional hubs that
drive islet and b cell identity and function.
GWASs have identified hundreds of loci that contribute to ge-
netic risk of T2D and other quantitativemeasures of islet dysfunc-
tion, such as glucose, insulin, and proinsulin levels (Fuchsberger
et al., 2016; Mahajan et al., 2018). We and others have linked a
subset of SNPs and loci to altered cis-RE activity and steady-
state islet gene expression (van de Bunt et al., 2015; Fadista
et al., 2014; Khetan et al., 2018; Varshney et al., 2017). For the
majority of loci, challenges remain to define the (1) causal or func-
tional SNP, (2) determine its molecular effect on cis-RE activity,
and (3) identify the putative target gene(s). By combining our
dense genotype and 3D chromatin interaction (ChIA-PET) net-
works in EndoC-bH1, we sought to identify SNPs with imbal-
anced expression or cis-REuse and link themphysically with their
target genes. Using this approach, we linked 91 out of 185
(H3K27ac imbalanced) and 21 out of 50 (ATAC-seq imbalanced)
SNPs to potential target genes (e.g., rs2294805 to SAMD5 in Fig-
ure 5B). Our ability to assess chromatin interactions between dia-
betes-associated SNPs and their target genes was modest.
Nonetheless, we identified two candidate SNPs (rs57235767,
rs3807136) that demonstrated consistent directions-of-effect
on measures of cis-RE activity (e.g., H3K27ac) and target gene
expression in EndoC-bH1 and human islets (Figure S5B) (Var-
shney et al., 2017). Several factors could underlie the modest
frequency of diabetes-associated GWAS SNPs linked by Pol2
ChIA-PET interactions: (1) limited sensitivity of ChIA-PET technol-
ogy, (2) condition or disease specificity of GWAS SNP effects on
cis-RE use or activity, or (3) condition-specific Pol2 interactions
between cis-REs and their target genes.
In summary, this study provides an integrated multiomic anal-
ysis of EndoC-bH1, a human pancreatic b cell line with increasing
utility and importance to the b cell and diabetes communities. In-
tegratedanalysisof chromatin interaction andgeneexpression in-
formation identified chromosomal territories and cis-regulatory
networks governing b cell identity and function. Overall, compar-
ison of EndoC-bH1 (epi)genomic and 3D chromatin profiles with
thoseof human islets verified commonsignaturesof gene expres-
sion, TF binding, and cis-RE use. These analyses also highlighted
genomic discrepancies between EndoC-bH1 and their primary
cell counterparts, possibly reflecting the fetal or embryonic origin
of the cell line and/or its transformed state. Integration of EndoC-
bH1cis-regulatorymapswith genome-widegenotype information
nominated target genes and identified SNP allelic effects on tran-
scriptional regulatory networks, including a subset of T2D-associ-
ated SNPs. Together, the data and tools provided here should
serve as helpful guides for rational design of targeted and hypoth-
esis-driven studies of candidate genes, pathways, or cis-REs to
determine their roles in b cell (dys)function and diabetes.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
H3K27ac-human antibody Abcam Abcam Cat# ab4729; RRID:AB_2118291
H3K4me3-mouse antibody Abcam Abcam Cat# ab12209; RRID:AB_442957
ENCODE Project Antibody validation H3K4me1 Abcam Abcam Cat# ab8895; RRID:AB_306847
ENCODE Project Antibody validation H3K36me3 Abcam Abcam Cat# ab9050; RRID:AB_306966
H3K27me3-celegans antibody Abcam Abcam Cat# ab6002; RRID:AB_305237
H3K79me2-human antibody Abcam Abcam Cat# ab3594; RRID:AB_303937
H3K9me3-human,H3K9me3-mouse antibody Abcam Abcam Cat# ab8898; RRID:AB_306848
Rabbit Anti-CTCF Polyclonal Antibody,
Unconjugated
Abcam Abcam Cat# ab70303; RRID:AB_1209546
RNA Polymerase II 8WG16 Monoclonal
Antibody, anti-RNA Polymerase II
Covance Research Products Covance Research Products Cat#
MMS-126R; RRID:AB_10013665
Biological Samples
Human pancreatic islet NDRI UNOS ID: ADAC418
Critical Commercial Assays
SKY Probe Applied Spectral Imaging INC Cat# FPRPR0028
HumanOmni2.5–4v1_H BeadChip Array Illumina Cat# WG-311-2514
TruSeq ChIP Sample Prep Kit Illumina Cat# IP-202-1024
TruSeq Stranded mRNA Kit Illumina Cat# 20020595
TruSeq Small RNA Library Kit Illumina Cat# RS-200-0036
Deposited Data
Raw and analyzed data This paper NCBI BioProject: PRJNA480287;
European Variation Archive: ERZ674947;
NCBI GEO: GSE118588
Islet ATAC-seq and RNA-seq Khetan et al., 2018 NCBI SRA: SRP117935
Purified beta and alpha cell ATAC-seq
and RNA-seq
Ackermann et al., 2016 NCBI GEO: GSE76268
Peripheral mononuclear blood cells
(PBMC) ATAC-seq
Ucar et al., 2017 European Genome-phenome Archive:
EGAS00001002605
PBMC RNA-seq ENCODE Project Consortium, 2012 NCBI GEO: GSE90275
Skeletal muscle ATAC-seq Scott et al., 2016 dbGap: phs001068.v1.p1
Skeletal muscle RNA-seq ENCODE Project Consortium, 2012 NCBI GEO: GSE78611
GM12878 and CD4+ T ATAC-seq Buenrostro et al., 2013 NCBI GEO: GSE47753
GM12878 RNA-seq Rozowsky et al., 2011 NCBI GEO: GSE30400
CD4+ T RNA-seq Schultz et al., 2015 NCBI GEO: GSE18927
Adipocyte RNA-seq ENCODE Project Consortium, 2012 NCBI GEO: GSE93486
GM12878 Hi-C Rao et al., 2014 NCBI GEO: GSE63525
K562 RNA Pol2 ChIA-PET Li et al., 2012 NCBI GEO: GSE39495
GM12878 RNA Pol2 ChIA-PET Tang et al., 2015 NCBI GEO: GSE72816
Experimental Models: Cell Lines
EndoC-betaH1: Cell line EndoCells/INSERM RRID: CVCL_L909
Software and Algorithms
Michigan Imputation Server Das et al., 2016 https://imputationserver.sph.umich.edu/index.html
Eagle v2.3 Loh et al., 2016 https://data.broadinstitute.org/alkesgroup/Eagle/
SHAPEIT v2.r790 Delaneau et al., 2011 http://mathgen.stats.ox.ac.uk/genetics_
software/shapeit/shapeit.html
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Michael
Stitzel (michael.stitzel@jax.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
EndoC-bH1 cell culture and processing
EndoC-bH1 cells provided by EndoCells/INSERM were cultured and passaged as previously described (Ravassard et al., 2011).
Briefly, cells were seeded at a density of approximately 600,000 cells/cm2 on tissue culture-treated plates pre-coated overnight
with extracellular matrix (Sigma) and fibronectin (Sigma) in EndoC-bH1 complete medium. Cells were passaged approximately every
7 days. Cells were harvested at various passages and distinct sites (e.g., NHGRI, JAX-GM) for karyotyping, genotyping, ATAC-seq,
ChIP-seq, RNA-seq, Hi-C, and Pol2 ChIA-PET analyses.
Human islet acquisition and procurement
The single human pancreatic islet sample (obtained from a cadaveric donor; UNOS ID: ADAC418; sex: Female; age: 43 years old)
used in this study was obtained from the National Disease Research Interchange (NDRI) and processed according to NHGRI insti-
tutional review board-approved protocols. The islet was shipped overnight from the distribution center. On receipt, we pre-warmed
the islet to 37C in shipping media for 1–2 h before harvest; 50,000 islet equivalents (IEQs) were harvested for Hi-C.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
minimac3 Das et al., 2016 https://genome.sph.umich.edu/wiki/Minimac3
PLINK version 1.9 Purcell et al., 2007 http://zzz.bwh.harvard.edu/plink/
Trimmomatic version 0.33 Bolger et al., 2014 http://www.usadellab.org/cms/?page=trimmomatic
BWA version 0.7.12 Li, 2013 http://bio-bwa.sourceforge.net
Samtools version 1.3.1 Li et al., 2009 http://samtools.sourceforge.net/
Picard-tools version 1.95 The Broad Institute, 2013 https://broadinstitute.github.io/picard/
Qualimap version 2.2.1 Okonechnikov et al., 2016 http://qualimap.bioinfo.cipf.es
MACS version 2.1.0 Zhang et al., 2008 http://liulab.dfci.harvard.edu/MACS/
BEDTools version 2.26.0 Quinlan and Hall, 2010 https://bedtools.readthedocs.io/en/latest/
deepTools version 2.4.2 Ramı´rez et al., 2014 https://deeptools.readthedocs.io/en/develop/
ChromHMM version 1.17 Ernst and Kellis, 2017 http://compbio.mit.edu/ChromHMM/
HOMER version 4.6 Heinz et al., 2010 http://homer.ucsd.edu/homer/index.html
STAR version 2.53 Dobin et al., 2013 https://github.com/alexdobin/STAR
QoRTs version 1.2.42 Hartley and Mullikin, 2015 https://hartleys.github.io/QoRTs/
miRquant 2.0 Kanke et al., 2016 https://github.com/Sethupathy-Lab/miRquant
Juicer Tools version 1.75 Durand et al., 2016a https://github.com/aidenlab/juicer/wiki/
Juicer-Tools-Quick-Start
Juicebox version 1.6.11 Durand et al., 2016b https://www.aidenlab.org/juicebox/
GREAT version 3.0 McLean et al., 2010 http://great.stanford.edu/public/html/
ChIA-PET2 version 0.9.2 Li et al., 2017a https://github.com/GuipengLi/ChIA-PET2
WASP version 0.2.2 van de Geijn et al., 2015 https://github.com/bmvdgeijn/WASP
Other
Haplotype Reference Consortium (HRC version,
hrc.r1.1.2016) panel
McCarthy et al., 2016 http://www.haplotype-reference-consortium.org/
NHGRI-EBI Catalog of SNPs N/A https://www.ebi.ac.uk/gwas/
R Shiny application for browsing human islet
and EndoC-bH1 genomic data
This paper http://shinyapps.jax.org/endoc-islet-multi-omics
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METHOD DETAILS
Spectral karyotyping (SKY)
Spectral karyotyping of EndoC-bH1 was completed to identify structural and numerical chromosome aberrations using standard
procedures as previously described. In brief, EndoC-bH1 cells were cultured to 80% confluence. Metaphase spreads were prepared
from these cells after mitotic arrest with Colcemid (0.015 mg/mL, 16 to 18 hours) (GIBCO, Gaithersburg, MD), hypotonic treatment
(0.075 mol/L KCl, 20 minutes, 37C), and fixation with methanol–acetic acid (3:1). Commercial SKY probe and software (Applied
Spectral Imaging INC, Carlsbad, CA) was used to identify and visualize the individually colored chromosomes obtained from two
slides’ worth of metaphase spreads from the same passage.
Genotyping, imputation, and phasing of EndoC-bH1
EndoC-bH1 was genotyped with the HumanOmni2.5–4v1_H BeadChip Array (Illumina, San Diego, CA, USA). We mapped the Illu-
mina array probe sequences to the hg19 genome assembly and excluded likely problematic ones as described in (Varshney
et al., 2017).
We applied the following filtering criteria to remove additional SNP probes prior to pre-phasing of the array genotypes: 1) we as-
sessed allele frequency of the SNPs using combined genotypes of EndoC-bH1 and 163 other samples that were genotyped on
similar chips; and 2) we removed SNPs with an alternate allele frequency difference with 1000G EUR samples > 20%, or palindromic
SNPs with a minor allele frequency > 20%, genotype missingness > 2.5%, Hardy-Weinberg p value < 104. At the end, a total of
1,851,388 SNPs were used in pre-phasing and imputation.
We performed pre-phasing and imputation separately on autosomal and chrX markers using the Michigan Imputation Server (Das
et al., 2016). We used Eagle v2.3 (Loh et al., 2016) for autosomal chip marker pre-phasing and SHAPEIT v2.r790 (Delaneau et al.,
2011) for chrX markers. We subsequently used minimac3 (Das et al., 2016) for imputation of missing genotypes using the Haplotype
Reference Consortium (HRC version, hrc.r1.1.2016) panel (McCarthy et al., 2016).
GWAS SNP pruning
Lists of reference SNP identifiers were obtained from the NHGRI-EBI Catalog of SNPs (https://www.ebi.ac.uk/gwas/; accessed
January 19th, 2017) for Type 2 diabetes, Type 1 diabetes, fasting glucose traits, fasting insulin traits, and proinsulin level categories.
For each disease category, GWAS SNPs were pruned using PLINK version 1.9 (Purcell et al., 2007) to identify SNPs in high linkage
disequilibrium (LD) (R2 > 0.8) using the parameters ‘‘–maf 0.05–clump–clump-p1 0.0001–clump-p2 0.01–clump-r2 0.8–clump-kb
1000’’ to ensure that each variant haplotype was tested only once during the enrichment analysis. For each SNP pair in LD
(R2 > 0.8) the SNP with the least significant p value was discarded. T2D-associated SNPs from (Mahajan et al., 2018) were obtained
and pruned using the same methodology described above.
ATAC-seq
EndoC-bH1 ATAC-seq libraries were prepared as previously described (Varshney et al., 2017) and sequenced on an Illumina
NextSeq 500 with 2 3 125 bp cycles. Raw sequence fastq files for adipocyte tissue, bulk islet (Khetan et al., 2018), islet beta and
alpha (GSE76268) (Ackermann et al., 2016), peripheral mononuclear blood cells (PBMC) (Ucar et al., 2017), skeletal muscle (Scott
et al., 2016), GM12878 and CD4+ T cells (GSE47753) (Buenrostro et al., 2013) were obtained from their corresponding studies.
Paired-end ATAC-seq reads were quality trimmed using Trimmomatic version 0.33 (Bolger et al., 2014) and parameters ‘‘TRAILING:3
SLIDINGWINDOW:4:15 MINLEN:36.’’ Trimmed reads were aligned to human genome (hg19) using BWA version 0.7.12 (Li, 2013),
specifically using the bwa mem –M option. Duplicate reads were removed using ‘‘MarkDuplicates’’ from Picard-tools version 1.95
(The Broad Institute, 2013). Quality of aligned reads were examined using Qualimap version 2.2.1 and default parameters
‘‘bamqc –bam –gd hg19.’’ (Okonechnikov et al., 2016). After preprocessing and quality filtering, peaks were called on alignments
with MACS version 2.1.0 (Zhang et al., 2008) using the parameters ‘‘-g ’hs’–nomodel–keep-dup all–broad–broad-cutoff 0.05 -f
BAMPE.’’ Peaks located in blacklisted regions of the genome were removed. Remaining overlapping peaks from all cell types
were merged with BEDTools version 2.26.0 (Quinlan and Hall, 2010) to generate a single peak set (n = 269,701). Raw read counts
in these peaks for each cell type were determined using the R packageDiffBind_2.4.8 (Ross-Innes et al., 2012). Spearman rank-order
correlation was calculated for cell types using the merged peaks with deepTools version 2.4.2 (Ramı´rez et al., 2014) and parameters
‘‘multiBamSummary BED-file –BED.’’
ChIP-seq
CTCF, H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K79me2, H3K4me3, H3K9me3 ChIP-seq was performed as previously
described (Stitzel et al., 2010) and sequenced on an Illumina HiSeq 2000 using 2 3 100 bp cycles. Harmonized ChromHMM (Ernst
and Kellis, 2017) states for EndoC-bH1 and NIH Roadmap cells/tissues were determined as previously described: ‘‘Chromatin states
were determined by applying the ChromHMM (version 1.10) hidden Markov model algorithm at 200-bp resolution to five chromatin
marks and input. We ran ChromHMM with a range of possible states and selected a 13-state model, because it most accurately
captured information from higher-state models and provided sufficient resolution to identify biologically meaningful patterns in a
reproducible way’’ (Varshney et al., 2017).
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Transcription factor motif enrichment analysis
‘‘findMotifsGenome.pl’’ (HOMER version 4.6 (Heinz et al., 2010)) script with parameters ‘‘hg19 -size 200’’ was used to determine TF
motifs enriched in ATAC-seq OCRs for each cell type (Figure 2C). In each analysis, all merged OCRs (n = 269,701) were provided as
background (e.g., EndoC-bH1 called OCRs (foreground) versus all merged OCRs (background)). The same parameters were used
to identify enriched motifs in either ‘‘Enhancers in Both EndoC-bH1 and Islet’’ (n = 16,351) or ‘‘Enhancers in EndoC-bH1 Only’’
(n = 19,380) compared to all enhancers (n = 51,325) (Figure 2D). The same HOMER script and parameters were also used to identify
enriched motifs in EndoC-bH1 (n = 315) versus GM12878 (n = 308) cell-specific Hi-C loops.
Similarity of cell/tissue type chromatin state (ChromHMM) annotations at EndoC-bH1 ATAC-seq OCRs
EndoC-bH1 ATAC-seq OCRs (n = 127,894) were overlapped with chromatin state (ChromHMM) annotations from EndoC-bH1,
human islet, adipocyte, skeletal muscle, GM12878, and PBMC cells provided in (Varshney et al., 2017). Next, only OCRs that
intersected a ChromHMM annotation from all tissue/cell types (n = 127,887/127,894) were retained (union set). Within a tissue/
cell type, or instances where multiple chromatin state elements intersected an EndoC-bH1 OCR, annotations were prioritized as fol-
lows: promoter, enhancer, transcription, repressed, or low signal. At each OCR, cell/tissue ChromHMM annotations were compared
to those of EndoC-bH1 and assigned a binary classification (1 = the annotations were the same, 0 = the annotations were different).
Aggregated counts of pairwise chromatin state annotations based on EndoC-bH1 OCRs were then computed for each tissue/cell
type, and a resulting similarity matrix was calculated using the ‘‘simil’’ function within the proxy version 0.4 R package (Meyer and
Buchta, 2018).
RNA-seq
Total RNA was extracted and purified from EndoC-bH1 using Trizol as previously described (Varshney et al., 2017). All sequencing
was performed on an Illumina NextSeq 500with 23 101 bp cycles. Raw fastq files for human islets (Khetan et al., 2018), islet beta and
alpha (Ackermann et al., 2016), PBMC (GSE90275), skeletal muscle (GSE78611), adipocyte (GSE93486) (ENCODE Project Con-
sortium, 2012), GM12878 (GSE30400) (Rozowsky et al., 2011), and CD4+ T cell (GSE18927) (Schultz et al., 2015) were obtained
from the associated databases. Paired-end RNA-seq reads were trimmed using Trimmomatic with the same parameters as used
for ATAC-seq reads. Trimmed reads were aligned to human genome (hg19) using STAR version 2.53 (Dobin et al., 2013) with default
parameters and expression levels of all genes were determined using QoRTs version 1.2.42 (Hartley and Mullikin, 2015) with default
parameters and Gencode v19 transcript annotations. A total of 27,564 protein-coding genes and long intergenic non-coding RNAs
(lincRNAs) were considered in the study.
miRNA-seq
Total RNA was extracted and purified from 2000-3000 islet equivalents (IEQ) or 2 3 106 EndoC-bH1 cells using Trizol (Life
Technologies). RNA quality was confirmed with Bioanalyzer 2100 (Agilent); islet samples with RNA integrity number (RIN) greater
than 6.5 were prepared for miRNA sequencing; EndoC- bH1 cells RNA RIN scores were > 9.0. miRNA libraries were prepared
at the NIH Intramural Sequencing Core (NISC) from 1 mg total RNA using Illumina’s TruSeq Small RNA Library Kit according to the
manufacturer’s guidelines, except a 10% acrylamide gel was used for better separation of library from adapters. Libraries were
pooled in groups of about 8 for gel purification. Single-end 51 base sequencing was performed on Illumina HiSeq 2500 sequencers
in Rapid Mode using version 2 chemistry. Data was processed using RTA version 1.18.64 and CASAVA 1.8.2. All resulting data was
processed with miRquant 2.0 (Kanke et al., 2016).
Hi-C
Hi-C libraries were generated as described in (Rao et al., 2014) and analyzed using the Juicer Tools version 1.75 pipeline (Durand
et al., 2016a). We sequenced 6,065,763,792 Hi-C read pairs in EndoC-bH1 cells, yielding 1,909,699,446 Hi-C contacts; we also
sequenced 6,009,242,588 Hi-C read pairs in islet cells, yielding 1,516,995,339 Hi-C contacts. Loci were assigned to A and B com-
partments at 500 kB resolution. Loops were annotated using HiCCUPS at 5kB and 10kB resolutions with default Juicer parameters.
This yielded a list of 9,100 loops in EndoC-bH1 cells and 2,580 loops in Islet cells. GM12878 loop calls (n = 9,448 loops) were down-
loaded fromGene Expression Omnibus (GSE63525). Differential loop calling with HiCCUPS at 5kb and 10kb identified 1,120 loops as
significantly enriched for EndoC-bH1 cells and 829 loops as significantly enriched for GM12878 cells. Similar comparison of islet and
EndoC-bH1 loops determined 935 loops as significantly enriched for EndoC-bH1 and 49 loops as being significantly enriched for
islet. Aggregate peak analysis (APA) plots were calculated using Juicer and the ‘‘apa’’ command using default parameters. Visual-
ization of Hi-C maps was performed using Juicebox version 1.6.11 (Durand et al., 2016b) with the ‘‘Observed/Expected’’ view and
‘‘Balanced’’ (Knight-Ruiz) normalization. All the code used in the above steps is publicly available at (https://github.com/theaidenlab).
Genomic Regions Enrichment of Annotations Tool (GREAT; (McLean et al., 2010) was used to identify pathways enriched in the single
nearest genes (whose TSS was within 2 kb) of EndoC-bH1-specific anchors.
ChIA-PET
EndoC-bH1 RNA Polymerase 2 (Pol2) ChIA-PET libraries were generated and sequenced reads were processed and analyzed ac-
cording to the protocol in (Li et al., 2017b). ChIA-PET interactions were identified using ChIA-PET2 (Li et al., 2017a) using the ‘‘bridge
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linker mode’’ option. Corresponding ChIA-PET interactions for K562 (GSE39495) and GM12878 (GSE72816) cells were obtained
fromGene Expression Omnibus. ChIA-PET andHi-C loopswere further filtered using the Bioconductor package InteractionSet_1.8.0
(Lun et al., 2016) to retain only those in which both interacting sites (anchors) overlappedOCRs. ChIA-PET anchors were annotated to
the nearest gene. To assess the physical connectivity between genes and their putative regulatory regions as captured by ChIA-PET
interactions, the number of distinct links between anchors annotated to each gene were counted and categorized by their chromatin
state and regulatory function. Counting was carried out both between each gene promoter and all linked regulatory regions (Fig-
ure 4C), and also between all annotated anchors regardless of their chromatin state and all linked regulatory regions (Figure S4B).
For example, consider anchors A1 and A2, both overlapping enhancer regions annotated to gene i. These anchors respectively
link to anchors B1, located in a TSS, and B2, in an enhancer. In this scenario, a connectivity degree of two would be computed
for gene i, corresponding to an enhancer-TSS and a TSS-TSS interaction, respectively.
The functional specificity of EndoC-bH1 ChIA-PET interactions was investigated by overlapping interaction anchors on
ChromHMM chromatin states computed from EndoC-bH1 data as well as 27 other tissue/cell types (Varshney et al., 2017), and
calculating the rate of conservation of chromatin states of both anchors. For example, a rate of 80%enhancer-enhancer conservation
would mean that 8 out of 10 interactions of this type in EndoC-bH1 are also found in another cell type. The resulting proportions were
computed for all interactions combined, and for specific relevant regulatory interactions (Figure 4D, line plots). In addition, aggre-
gated counts of pairwise chromatin state interactions based on EndoC-bH1 ChIA-PET interactions were computed for the same
cell types as above, and pairwise distances (D) between the resulting 29 count matrices were computed and plotted as scaled sim-
ilarity values relative to EndoC-bH1 (i.e., 1-D/Dmax), so thatD = 0 for EndoC-bH1 interactions andD = Dmax for the most divergent cell
type (Figure 4D, bar plot). These same methods were used to determine the functional specificity of EndoC-bH1 Hi-C interactions.
ATAC-seq allelic bias analysis
All allelic bias analyseswere performed usingWASP (van deGeijn et al., 2015) (version 0.2.2 after GitHub commit 5a52185 and bug fix
in pull request #67). For the EndoC-bH1 ATAC-seq allelic bias analyses, after original BWAmapping, reads were filtered to properly-
paired, high-quality autosomal reads using SAMtools (v. 1.3.1; flags -f 3 -F 4 -F 8 -F 256 -F 2048 -q 30) (Li et al., 2009). Remapping and
filtering as part of the WASP pipeline utilized the same parameters. As the last step of the WASP pipeline, duplicate removal was
performed using WASP’s rmdup_pe.py script. In order to avoid double-counting SNPs covered by both reads in a pair, overlapping
read pairs were clipped using bamUtil’s clipOverlap (https://genome.sph.umich.edu/wiki/BamUtil:_clipOverlap; v. 1.0.14). The four
replicate libraries were then merged using SAMtools merge.
For each SNP, we determined the number of reads containing each allele (requiring base quality of at least 20). We excluded SNPs
with total coverage less than 10, as well as SNPs in regions blacklisted by the ENCODE Consortium because of poor mappability
(wgEncodeDacMapabilityConsensusExcludable.bed and wgEncodeDukeMapabilityRegionsExcludable.bed). Allelic bias testing
was performed using a two-tailed binomial test, using an adjusted expectation for the null to account for residual reference bias
as described in (Scott et al., 2016). Briefly, for each of the 16 reference-alternate allele pairs (e.g., AG andGA are separate allele pairs),
we calculated the expected fraction of reference alleles (fracRef) under the null as the sum of the reference allele counts divided by
the sum of the total allele counts for SNPs of that allele pair. To prevent SNPs of high coverage from biasing the expected fracRef, we
down-sampled SNPs with coverage in the top 25th percentile to the median coverage, and used these downsampled reference and
total allele counts when calculating the expected fracRef. We used the observed allele-pair specific fracRef as the true fracRef under
the null hypothesis of no allelic bias in the binomial test. Multiple testing correction was performed using the Benjamini-Hochberg
correction (FDR < 10%).
ChIP-seq allelic bias analysis
For the EndoC-bH1 ChIP-seq allelic bias analyses, paired-end libraries were processed as follows. Adapters were trimmed using cta
(v. 0.1.2) and readsmapped using BWAmem (-M flag; v. 0.7.12). Readswere filtered to properly-paired, high-quality autosomal reads
using SAMtools (flags -f 3 -F 4 -F 8 -F 256 -F 2048 -q 30). Single-end libraries were mapped using BWA aln (v. 0.7.12; default param-
eters) and filtered using SAMtools (flags -F 4 -F 256 -F 2048 -q 30). Remapping and filtering as part of the WASP pipeline utilized the
same parameters as for the original mapping. For paired-end libraries, overlapping read pairs were clipped using bamUtil’s
clipOverlap. Replicates were merged using SAMtools merge. Allele counting and allelic bias testing was performed as described
above for ATAC-seq.
RNA-seq allelic bias analysis
For the EndoC-bH1 RNA-seq allelic bias analyses, after original STAR mapping, reads were filtered to properly-paired, high-quality
autosomal reads using SAMtools (v. 1.3.1; flags -f 3 -F 4 -F 8 -F 256 -F 2048 -q 255). Remapping and filtering as part of the WASP
pipeline utilized the same parameters. In order to avoid double-counting SNPs covered by both reads in a pair, overlapping read pairs
were clipped using bamUtil’s clipOverlap. Allele counting and allelic bias testing was performed as described above for ATAC-seq.
Comparison of islet eQTL and EndoC-bH1 biased SNPs allelic effect
Human islet eQTL data were obtained from (Varshney et al., 2017). For EndoC-bH1 biased (H3K27ac) enhancer SNPs that were also
linked (via ChIA-PET chromatin interaction) to a target gene (n = 91/185 SNPs in Figure 5C), all corresponding islet eQTL SNP-gene
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pairs were retrieved. For 42/91 SNPs linked to target genes, the H3K27ac allelic effect bias was calculated assuming that the EndoC-
bH1 effect allele was the same as the islet eQTL effect allele. Allelic effect bias was calculated by dividing the effect allele coverage
(either reference or alternate allele) by the total coverage of the SNP. A scalar value of 0.5 was subtracted from this value to determine
whether the effect allele had an increased (positive value), decreased (negative value), or no (zero) bias in H3K27ac coverage.
Randomly selected eQTL SNP-gene pairs that did not have corresponding connections (via ChIA-PET chromatin interaction) to a
target gene were considered as a null/background set.
QUANTIFICATION AND STATISTICAL ANALYSIS
Visualization of all Hi-C, ChIA-PET, chromatin state (ChromHMM), ATAC-seq, and RNA-seq data examined in this study (Figures 1, 2,
3, 4, and 5) were produced with R using ggplot2_3.0.0 (Wickham, 2016), pheatmap_1.0.10 (Kolde, 2018), Sushi_1.18.0 (Phanstiel
et al., 2014), as well as Juicer Tools (Figure 3) (Durand et al., 2016a) and Juicebox (Figure 3) (Durand et al., 2016b).
DATA AND SOFTWARE AVAILABILITY
The accession numbers for EndoC-bH1 Hi-C, ChIA-PET, ChIP-seq, ATAC-seq, RNA-seq, miRNA-seq as well as human islet Hi-C
data reported in this paper are: NCBI BioProject accession PRJNA480287, NCBI Gene Expression Omnibus accession
GSE118588. The accession number for EndoC-bH1 genotype data is: European Variation Archive accession ERZ674947 and project
PRJEB27824. The R shiny web application to visualize and interact with themulti-omic data generated in this study is freely available
at https://shinyapps.jax.org/endoc-islet-multi-omics/. Interactive Hi-C maps are available at aidenlab.org/juicebox.
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SKY EndoC-βH1 Metaphase 7 47,XY,t(7;18),-10,t(10;17),t(3;17),der(17)t(3;17),+20
SKY EndoC-βH1 Metaphase S2.7 48,XY,t(3;21),-10,+der(17)t(10;17),+20
Common event to 
multiple metaphases
Figure S1, related to Figure 1: Representative spectral karyotypes (SKY) of EndoC-ßH1 cells at metaphase. 
Specific metaphases shown are S2.1 (top), 7 (middle), and S2.7 (bottom). Common structural or numerical 
chromosomal aberrations that are evident in multiple metaphases are indicated in green. 
A Similarity of cell type chromatin states to EndoC-βH1
C PCA of EndoC-βH1 and other tissue miRNA profiles D Correlation of EndoC-βH1 and Islet miRNA profiles
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Figure S2, related to Figure 2: Comparison of EndoC-ßH1 and islet epigenomic and transcriptomic profiles.
(A) Similarity (centered Pearson correlation) of human islet, adipocyte, skeletal muscle, GM12878, and PBMC
chromatin state annotations (ChromHMM) to those of EndoC-ßH1 at EndoC-ßH1 OCRs. The similarity matrix
was calculated using the “simil” function within the proxy version 0.4 R package (Meyer and Buchta, 2018). 
(B) Spearman correlation between EndoC-ßH1 RNA-seq and the corresponding RNA-seq from islets,
sorted alpha or beta cells (Ackermann et al., 2016), and other cell types and tissues. PBMC=peripheral 
blood mononuclear cells, GM12878 = lymphoblastoid cell line, CD4T = CD4+ T immune cell, 
skeletal = skeletal muscle, Alpha = primary islet alpha cells, Beta = primary islet beta cells. 
(C) Principal component analysis (PCA) of miRNA-seq profiles from EndoC-ßH1 and 5 representative
human islet, skeletal muscle, and adipose tissue samples. (D) Scatter plot illustrating the resemblance of 
miRNA expression levels between EndoC-ßH1 and human islets. RPMMM = reads per million mapped miRNA,
R = Pearson R.  
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Figure S3, related to Figure 3: Enrichment analysis and annotation of EndoC-ßH1 Hi-C loops.
(A) Biological process gene ontology terms enriched in genes adjacent to EndoC-ßH1-specific Hi-C anchors. Enrichment 
analysis was performed with GREAT (McLean et al., 2010) using the single gene whose transcription start site (TSS) was 
nearest to each anchor. Results with an adjusted (Benjamini & Hochberg) hypergeometric p-value < 0.05 were regarded as
statistically significant. (B) Frequency of EndoC-ßH1 Hi-C loop anchors and their corresponding chromatin state (ChromHMM)
annotations. (C) (Top) Bar plot depicting the average similarity of chromatin state (ChromHMM) annotations for each cell type at 
EndoC-ßH1 Hi-C loop anchor positions. Overlaid line plots highlight the relative similarity for various chromatin state interactions
(e.g. active promoter vs. active promoter). (Bottom) Select heat maps showing the frequency of human islet (left) and 
GM12878 (right) chromatin states at EndoC-ßH1 loop anchors. 
CB Network connectivity of EndoC-βH1 anchor genes
MDS based on dissimilarity with EndoC-βH1 chromHMM states
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Figure S4, related to Figure 4: Annotation and evaluation of EndoC-ßH1 RNA Pol2 ChIA-PET interactions. 
(A) Genome-wide view of RNA polymerase 2-mediated (Pol2 ChIA-PET) chromatin interactions around the PDX1 locus on
chromosome 13 in EndoC-ßH1. Asterisks under EndoC-ßH1 (red) ChIA-PET interactions indicate interacting sites/anchors
identified by targeted 4C-seq analyses in this locus in human islets (Pasquali et al., 2014). (B) Connectivity of EndoC-ßH1 ChIA-PET 
interactions when considering nodes with 6 or more links to other regulatory elements. (Left) Circular plots depict the number of 
links that occur with corresponding regulatory elements (e.g., active promoter, active enhancer). (Right) bar plots illustrate the
proportion of interacting nodes that exhibit the active regulatory element chromatin states exclusively in EndoC-ßH1 (blue) or
identical chromatin states in both EndoC-ßH1 and islet (green). (C) Multidimensional scaling (MDS) plot based on pairwise 
Chi-square distances of vectors  of proportions of chromatin states in EndoC-ßH1, islets, and additional Epigenomics Roadmap
cell and tissue types at EndoC-ßH1 defined ChIA-PET interacting nodes. 
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Figure S5, related to Figure 5: Assessment of cis-regulatory element allelic imbalance in
EndoC-ßH1 and islets.
(A) Correlation of cis-regulatory element allelic imbalance for SNPs with heterozygous
genotypes in EndoC-ßH1. For a given heterozygous SNP (n = 1,734 total with 20X coverage
in EndoC-ßH1 ATAC-seq and H327ac data), allelic imbalance ratios were calculated and
plotted. Colored points signify SNPs with significant allelic imbalance (FDR < 10%) in 
ATAC-seq (red), H3K27ac (blue), or both (purple) datasets. (B) Correlation of human islet
eQTL SNP-gene pair direction of effect (z-score) from (Varshney et al., 2017) and their
corresponding H3K27ac effect allele bias deviation from 0.5 in EndoC-ßH1. Red points
indicate eQTL SNP-gene pairs that are also linked by an EndoC-ßH1 ChIA-PET interaction.
Asterisks indicate eQTL SNPs that are also diabetes-associated GWAS SNPs.
